Eris Lifesciences Limited Share Price & Analysis
₹1,470▲ +0.46%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹1,470
+0.46%
Open
₹—
High
₹1,475
Low
₹1,445
Close
₹1,470
52W High
₹1,888
52W Low
₹1,200
Volume
79K
Lot Size
1
Sector
Healthcare
Market Cap
₹20K Cr
Face Value
₹1
Large CapNIFTY 500
Price Chart
Fundamentals
P/E
31.9
Sector P/E
54.4
P/B
6
EPS
₹45.21
ROE
18.7%
ROCE
14.1%
D/E Ratio
0.61
Div Yield
0.51%
Book Value
₹282
+
Strengths
- ✓Strong return on equity (ROE 18.7%)
- ✓Attractively valued vs sector (P/E 31.9x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ERIS · as of Mar 2026
Promoters54.85%
FII8.43%▲0.07
DII18.07%
Public18.64%▼0.09
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.90% | 54.90% | 54.88% | 54.87% | 54.86% | 54.85% |
| FII | 13.13% | 14.27% | 14.59% | 8.01% | 8.36% | 8.43% |
| DII | 14.55% | 15.63% | 16.23% | 18.64% | 18.07% | 18.07% |
| Public | 17.41% | 15.20% | 14.30% | 18.47% | 18.73% | 18.64% |
Corporate Events
Interim Dividend - Rs 7.21 Per Share
Dividend28 May 2026
Interim Dividend - Rs 7.35 Per Share
Dividend12 Feb 2025
Annual General Meeting
AGM16 Sept 2024
Annual General Meeting
AGM14 Sept 2023
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹757 Cr ▼6.2% | ₹807 Cr ▲1.9% | ₹792 Cr ▲2.5% | ₹773 Cr ▲9.6% | ₹705 Cr ▼3.0% | ₹727 Cr ▼1.9% | ₹741 Cr ▲2.9% | ₹720 Cr |
| Op. Profit | ₹272 Cr ▼3.5% | ₹282 Cr ▼2.1% | ₹288 Cr ▲4.0% | ₹277 Cr ▲9.9% | ₹252 Cr ▲0.8% | ₹250 Cr ▼5.7% | ₹265 Cr ▲6.0% | ₹250 Cr |
| OPM | 36.0% ▲2.9% | 35.0% ▼2.8% | 36.0% ▲0.0% | 36.0% ▲0.0% | 36.0% ▲5.9% | 34.0% ▼5.6% | 36.0% ▲2.9% | 35.0% |
| Net Profit | ₹279 Cr ▲156.0% | ₹109 Cr ▼18.7% | ₹134 Cr ▲7.2% | ₹125 Cr ▲22.5% | ₹102 Cr ▲17.2% | ₹87 Cr ▼9.4% | ₹96 Cr ▲6.7% | ₹90 Cr |
| EPS (₹) | 20.33 ▲177.7% | 7.32 ▼17.0% | 8.82 ▲1.8% | 8.66 ▲25.7% | 6.89 ▲12.0% | 6.15 ▼8.6% | 6.73 ▲10.0% | 6.12 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.1K Cr ▲8.1% | ₹2.9K Cr ▲44.1% | ₹2.0K Cr ▲19.2% | ₹1.7K Cr ▲25.1% | ₹1.3K Cr ▲11.1% | ₹1.2K Cr ▲12.8% | ₹1.1K Cr ▲9.4% | ₹982 Cr ▲14.7% | ₹856 Cr ▲14.1% | ₹750 Cr |
| Expenses | ₹2.0K Cr ▲7.1% | ₹1.9K Cr ▲40.8% | ₹1.3K Cr ▲16.2% | ₹1.1K Cr ▲33.6% | ₹858 Cr ▲9.9% | ₹781 Cr ▲11.3% | ₹702 Cr ▲10.2% | ₹637 Cr ▲19.5% | ₹533 Cr ▲11.0% | ₹480 Cr |
| Op. Profit | ₹1.1K Cr ▲10.0% | ₹1.0K Cr ▲50.4% | ₹677 Cr ▲25.6% | ₹539 Cr ▲10.2% | ₹489 Cr ▲13.5% | ₹431 Cr ▲15.9% | ₹372 Cr ▲7.8% | ₹345 Cr ▲7.1% | ₹322 Cr ▲19.7% | ₹269 Cr |
| OPM | 36.0% ▲2.9% | 35.0% ▲2.9% | 34.0% ▲6.3% | 32.0% ▼11.1% | 36.0% ▲0.0% | 36.0% ▲2.9% | 35.0% ▲0.0% | 35.0% ▼7.9% | 38.0% ▲5.6% | 36.0% |
| Other Income | ₹-9 Cr ▼150.0% | ₹18 Cr ▼18.2% | ₹22 Cr ▲144.4% | ₹9 Cr ▼59.1% | ₹22 Cr ▲144.4% | ₹9 Cr ▼25.0% | ₹12 Cr ▼61.3% | ₹31 Cr ▲19.2% | ₹26 Cr ▲4.0% | ₹25 Cr |
| Interest | ₹193 Cr ▼16.5% | ₹231 Cr ▲171.8% | ₹85 Cr ▲226.9% | ₹26 Cr ▲550.0% | ₹4 Cr ▲100.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼91.3% | ₹23 Cr ▲109.1% | ₹11 Cr ▲1000.0% | ₹1 Cr |
| Depreciation | ₹280 Cr ▼11.1% | ₹315 Cr ▲72.1% | ₹183 Cr ▲56.4% | ₹117 Cr ▲80.0% | ₹65 Cr ▲51.2% | ₹43 Cr ▼14.0% | ₹50 Cr ▲38.9% | ₹36 Cr ▲38.5% | ₹26 Cr ▲13.0% | ₹23 Cr |
| PBT | ₹639 Cr ▲30.7% | ₹489 Cr ▲13.5% | ₹431 Cr ▲6.4% | ₹405 Cr ▼8.4% | ₹442 Cr ▲12.2% | ₹394 Cr ▲19.0% | ₹331 Cr ▲4.4% | ₹317 Cr ▲1.6% | ₹312 Cr ▲15.6% | ₹270 Cr |
| Tax % | -1.0% ▼104.3% | 23.0% ▲187.5% | 8.0% ▲0.0% | 8.0% ▲0.0% | 8.0% ▼20.0% | 10.0% ▼9.1% | 11.0% ▲37.5% | 8.0% ▲33.3% | 6.0% ▼33.3% | 9.0% |
| Net Profit | ₹648 Cr ▲72.8% | ₹375 Cr ▼5.5% | ₹397 Cr ▲6.1% | ₹374 Cr ▼7.9% | ₹406 Cr ▲14.4% | ₹355 Cr ▲19.5% | ₹297 Cr ▲2.1% | ₹291 Cr ▼1.4% | ₹295 Cr ▲19.4% | ₹247 Cr |
| EPS (₹) | 44.72 ▲73.1% | 25.84 ▼10.3% | 28.82 ▲2.6% | 28.1 ▼6.0% | 29.88 ▲14.2% | 26.16 ▲19.8% | 21.84 ▲3.3% | 21.15 ▼1.1% | 21.39 ▲19.2% | 17.95 |
| Div Payout | 16.0% ▼42.9% | 28.0% | 0.0% ▼100.0% | 26.0% ▲30.0% | 20.0% ▼4.8% | 21.0% ▲61.5% | 13.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr |
| Reserves | ₹3.9K Cr ▲36.9% | ₹2.8K Cr ▲10.4% | ₹2.6K Cr ▲17.9% | ₹2.2K Cr ▲15.1% | ₹1.9K Cr ▲21.2% | ₹1.6K Cr ▲21.8% | ₹1.3K Cr ▲12.8% | ₹1.1K Cr ▲34.1% | ₹848 Cr ▲53.3% | ₹553 Cr |
| Borrowings | ₹2.4K Cr ▼4.8% | ₹2.5K Cr ▼10.9% | ₹2.8K Cr ▲217.1% | ₹877 Cr ▲944.0% | ₹84 Cr ▲1100.0% | ₹7 Cr | ₹0 Cr ▼100.0% | ₹176 Cr ▼53.3% | ₹377 Cr ▲37600.0% | ₹1 Cr |
| Other Liabilities | ₹1.1K Cr ▼21.8% | ₹1.4K Cr ▲3.4% | ₹1.4K Cr ▲305.3% | ₹337 Cr ▲44.6% | ₹233 Cr ▲15.3% | ₹202 Cr ▼1.5% | ₹205 Cr ▲17.1% | ₹175 Cr ▲2.9% | ₹170 Cr ▲37.1% | ₹124 Cr |
| Total Liabilities | ₹7.4K Cr ▲9.2% | ₹6.7K Cr ▲0.1% | ₹6.7K Cr ▲97.5% | ₹3.4K Cr ▲53.2% | ₹2.2K Cr ▲24.7% | ₹1.8K Cr ▲18.8% | ₹1.5K Cr ▲0.0% | ₹1.5K Cr ▲6.7% | ₹1.4K Cr ▲103.5% | ₹692 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹5.2K Cr ▼2.2% | ₹5.3K Cr ▲22.9% | ₹4.3K Cr ▲68.2% | ₹2.6K Cr ▲179.7% | ₹918 Cr ▲7.5% | ₹854 Cr ▼2.4% | ₹875 Cr ▲15.0% | ₹761 Cr ▼1.3% | ₹771 Cr ▲232.3% | ₹232 Cr |
| CWIP | ₹171 Cr ▲155.2% | ₹67 Cr ▲235.0% | ₹20 Cr ▼9.1% | ₹22 Cr ▼18.5% | ₹27 Cr ▲1250.0% | ₹2 Cr ▼50.0% | ₹4 Cr ▲33.3% | ₹3 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹62 Cr ▼7.5% | ₹67 Cr ▲318.8% | ₹16 Cr ▼56.8% | ₹37 Cr ▼92.9% | ₹520 Cr ▲76.9% | ₹294 Cr ▲276.9% | ₹78 Cr ▼78.1% | ₹356 Cr ▼2.5% | ₹365 Cr ▲20.5% | ₹303 Cr |
| Other Assets | ₹1.9K Cr ▲49.2% | ₹1.3K Cr ▼45.2% | ₹2.4K Cr ▲203.8% | ₹783 Cr ▲2.9% | ₹761 Cr ▲19.7% | ₹636 Cr ▲16.9% | ₹544 Cr ▲42.0% | ₹383 Cr ▲41.3% | ₹271 Cr ▲72.6% | ₹157 Cr |
| Total Assets | ₹7.4K Cr ▲9.2% | ₹6.7K Cr ▲0.1% | ₹6.7K Cr ▲97.5% | ₹3.4K Cr ▲53.2% | ₹2.2K Cr ▲24.7% | ₹1.8K Cr ▲18.8% | ₹1.5K Cr ▲0.0% | ₹1.5K Cr ▲6.7% | ₹1.4K Cr ▲103.5% | ₹692 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹538 Cr ▼49.5% | ₹1.1K Cr ▲119.1% | ₹486 Cr ▲66.4% | ₹292 Cr ▼22.8% | ₹378 Cr ▲0.8% | ₹375 Cr ▲38.4% | ₹271 Cr ▲21.5% | ₹223 Cr ▼5.1% | ₹235 Cr ▲17.5% | ₹200 Cr |
| Investing CF | ₹-369 Cr ▼373.1% | ₹-78 Cr ▲95.7% | ₹-1.8K Cr ▼87.5% | ₹-975 Cr ▼204.7% | ₹-320 Cr ▲0.9% | ₹-323 Cr ▼362.6% | ₹123 Cr ▲2560.0% | ₹-5 Cr ▲99.2% | ₹-590 Cr ▼220.7% | ₹-184 Cr |
| Financing CF | ₹-314 Cr ▲64.4% | ₹-881 Cr ▼163.8% | ₹1.4K Cr ▲100.6% | ₹688 Cr ▲1628.9% | ₹-45 Cr ▲45.1% | ₹-82 Cr ▲75.5% | ₹-335 Cr ▼51.6% | ₹-221 Cr ▼160.9% | ₹363 Cr ▲1612.5% | ₹-24 Cr |
| Net Cash Flow | ₹-145 Cr ▼238.1% | ₹105 Cr ▲176.3% | ₹38 Cr ▲660.0% | ₹5 Cr ▼64.3% | ₹14 Cr ▲146.7% | ₹-30 Cr ▼150.0% | ₹60 Cr ▲2100.0% | ₹-3 Cr ▼137.5% | ₹8 Cr ▲200.0% | ₹-8 Cr |
| Free Cash Flow | ₹241 Cr ▼73.5% | ₹910 Cr ▲154.9% | ₹357 Cr ▲164.9% | ₹-550 Cr ▼313.2% | ₹258 Cr ▼26.3% | ₹350 Cr ▲180.0% | ₹125 Cr ▼32.8% | ₹186 Cr ▼11.4% | ₹210 Cr ▲40.0% | ₹150 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 79d ▲36.2% | 58d ▼24.7% | 77d ▲22.2% | 63d ▲43.2% | 44d ▲4.8% | 42d ▼20.8% | 53d ▲71.0% | 31d ▲10.7% | 28d ▲16.7% | 24d |
| Inventory Days | 200d ▲17.0% | 171d ▼6.0% | 182d ▲33.8% | 136d ▼18.1% | 166d ▲14.5% | 145d ▼2.0% | 148d ▼24.5% | 196d ▲10.1% | 178d ▼8.7% | 195d |
| Days Payable | 151d ▼11.2% | 170d ▼19.0% | 210d ▲62.8% | 129d ▼22.3% | 166d ▲5.7% | 157d ▼26.3% | 213d ▲6.5% | 200d ▼19.0% | 247d ▲84.3% | 134d |
| Cash Conv. Cycle | 129d ▲118.6% | 59d ▲22.9% | 48d ▼31.4% | 70d ▲59.1% | 44d ▲46.7% | 30d ▲350.0% | -12d ▼142.9% | 28d ▲170.0% | -40d ▼147.6% | 84d |
| Working Capital Days | -71d ▼44.9% | -49d ▲83.4% | -296d ▼692.0% | 50d ▼33.3% | 75d ▲17.2% | 64d ▲8.5% | 59d ▲447.1% | -17d ▼30.8% | -13d ▼156.5% | 23d |
| ROCE | 14.0% ▲16.7% | 12.0% ▲9.1% | 11.0% ▼35.3% | 17.0% ▼32.0% | 25.0% ▼7.4% | 27.0% ▲8.0% | 25.0% ▼3.8% | 26.0% ▼23.5% | 34.0% ▼43.3% | 60.0% |
Source: Screener.in · Lower days = better efficiency
About Eris Lifesciences Limited
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Eris Lifesciences Limited share price today?▾
Eris Lifesciences Limited (ERIS) is currently trading at ₹1,470 on NSE, up 0.46% as of the last market session. Prices update daily after market close on MarketNetra.
Is Eris Lifesciences Limited available in F&O (Futures & Options)?▾
Yes, Eris Lifesciences Limited (ERIS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Eris Lifesciences Limited 52-week high and low?▾
Eris Lifesciences Limited's 52-week high is ₹1,888 and the 52-week low is ₹1,200. The current price of ₹1,470 is 22.1% below the 52W high.
What is Eris Lifesciences Limited P/E ratio?▾
Eris Lifesciences Limited's current P/E ratio is 31.9. This indicates the market is paying ₹31.9 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Eris Lifesciences Limited options?▾
Eris Lifesciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ERIS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.